Patents by Inventor Chelsea Bahney

Chelsea Bahney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273695
    Abstract: The present disclosure is related to methods of stimulating bone formation for the purpose of improving bone repair, accelerating bone healing, and/or generating new bone in a local region with absent or diminished bone due to injury, disease, or defect, comprising administering a composition comprising ?-catenin mRNA complex to the subject.
    Type: Application
    Filed: March 1, 2022
    Publication date: September 1, 2022
    Inventors: Chelsea BAHNEY, Ralph MARCUCIO, Gianluca FONTANA, William L. MURPHY, John P. COOKE, Daniel L. KISS, Francesca TARABALLI, Nicole EHRHART, Anna-Laura NELSON
  • Publication number: 20220218874
    Abstract: A method of modulating transdifferentiation of chondrocytes to osteoblast includes administering to the chondrocytes an agent that modulates GP130 receptor signaling and expression of at least one of Sox2, Oct4, or Nanog of the chondrocytes.
    Type: Application
    Filed: August 24, 2021
    Publication date: July 14, 2022
    Inventors: Eben Alsberg, Oju Jeon, Ralph Marcucio, Chelsea Bahney, Diane Hu, Sarah Knox
  • Publication number: 20220152152
    Abstract: The present disclosure is related to methods for stimulating bone fracture healing, comprising administering a pharmaceutical composition comprising biomaterial carriers comprising painless nerve growth factor (NGF).
    Type: Application
    Filed: November 17, 2021
    Publication date: May 19, 2022
    Inventors: Chelsea BAHNEY, Tejal DESAI, Kevin RIVERA, Chengbiao WU
  • Patent number: 11097034
    Abstract: A method of modulating transdifferentiation of chondrocytes to osteoblast includes administering to the chondrocytes an agent that modulates GP130 receptor signaling and expression of at least one of Sox2, Oct4, or Nanog of the chondrocytes.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: August 24, 2021
    Assignees: CASE WESTERN RESERVE UNIVERSITY, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Eben Alsberg, Oju Jeon, Ralph Marcucio, Chelsea Bahney, Diane Hu, Sarah Knox
  • Publication number: 20190358364
    Abstract: A method of modulating transdifferentiation of chondrocytes to osteoblast includes administering to the chondrocytes an agent that modulates GP130 receptor signaling and expression of at least one of Sox2, Oct4, or Nanog of the chondrocytes.
    Type: Application
    Filed: December 11, 2017
    Publication date: November 28, 2019
    Inventors: Eben Alsberg, Oju Jeon, Ralph Marcucio, Chelsea Bahney, Diane Hu, Sarah Knox
  • Publication number: 20190150882
    Abstract: Described herein is an implantable device configured to detect impedance characteristic of a tissue.
    Type: Application
    Filed: July 7, 2017
    Publication date: May 23, 2019
    Inventors: Michel M. Maharbiz, Jose M. Carmena, Dongjin Seo, Monica Lin, Meir Marmor, Safa Herfat, Chelsea Bahney